Gilead Sciences - GILD Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $73.53
  • Forecasted Upside: 19.20 %
  • Number of Analysts: 14
  • Breakdown:
  • 1 Sell Ratings
  • 9 Hold Ratings
  • 4 Buy Ratings
  • 0 Strong Buy Ratings
$61.69
▼ -1.38 (-2.19%)

This chart shows the closing price for GILD by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Gilead Sciences Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for GILD and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for GILD

Analyst Price Target is $73.53
▲ +19.20% Upside Potential
This price target is based on 14 analysts offering 12 month price targets for Gilead Sciences in the last 3 months. The average price target is $73.53, with a high forecast of $90.00 and a low forecast of $56.00. The average price target represents a 19.20% upside from the last price of $61.69.

This chart shows the closing price for GILD for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Hold

The current consensus among 14 investment analysts is to hold stock in Gilead Sciences. This Hold consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 10 buy ratings
  • 13 hold ratings
  • 1 sell ratings
4/10/2021
  • 0 strong buy ratings
  • 7 buy ratings
  • 13 hold ratings
  • 0 sell ratings
7/9/2021
  • 0 strong buy ratings
  • 6 buy ratings
  • 11 hold ratings
  • 0 sell ratings
10/7/2021
  • 0 strong buy ratings
  • 6 buy ratings
  • 8 hold ratings
  • 0 sell ratings
1/5/2022
  • 0 strong buy ratings
  • 6 buy ratings
  • 9 hold ratings
  • 1 sell ratings
4/5/2022
  • 0 strong buy ratings
  • 4 buy ratings
  • 8 hold ratings
  • 1 sell ratings
7/4/2022
  • 0 strong buy ratings
  • 4 buy ratings
  • 9 hold ratings
  • 1 sell ratings
9/2/2022
  • 0 strong buy ratings
  • 4 buy ratings
  • 9 hold ratings
  • 1 sell ratings
10/2/2022

Latest Recommendations

  • 0 strong buy ratings
  • 4 buy ratings
  • 9 hold ratings
  • 1 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
9/15/2022SVB LeerinkReiterated RatingMarket PerformLow
9/15/2022Truist FinancialBoost TargetHold$71.00 ➝ $76.00Low
9/13/2022Wells Fargo & CompanyBoost TargetEqual Weight$63.00 ➝ $74.00Low
9/12/2022Piper SandlerBoost Target$74.00 ➝ $79.00Low
8/15/2022Piper SandlerBoost Target$71.00 ➝ $74.00Low
7/15/2022Morgan StanleyBoost TargetEqual Weight$63.00 ➝ $65.00Low
7/12/2022Cantor FitzgeraldInitiated CoverageNeutral$70.00N/A
6/7/2022BMO Capital MarketsInitiated CoverageHold$63.00High
5/23/2022SVB LeerinkInitiated CoverageMarket Perform$68.00Low
5/16/2022Piper SandlerLower TargetNeutral$73.00 ➝ $69.00N/A
4/29/2022Piper SandlerBoost Target$72.00 ➝ $73.00High
4/12/2022Morgan StanleyLower TargetEqual Weight$69.00 ➝ $63.00Low
4/12/2022Royal Bank of CanadaBoost TargetOutperform$76.00 ➝ $77.00Low
4/12/2022Piper SandlerBoost Target$71.00 ➝ $72.00Low
4/4/2022Piper SandlerLower TargetNeutral$77.00 ➝ $71.00Medium
3/22/2022Wells Fargo & CompanyLower TargetEqual Weight$70.00 ➝ $63.00Low
3/10/2022BarclaysLower TargetUnderweight$63.00 ➝ $56.00High
3/8/2022BMO Capital MarketsInitiated CoverageHold$65.00Medium
3/7/2022Royal Bank of CanadaLower TargetOutperform$85.00 ➝ $77.00High
2/28/2022BMO Capital MarketsDowngradeOutperform ➝ Market Perform$75.00 ➝ $65.00Low
2/8/2022MizuhoLower TargetBuy$81.00 ➝ $75.00Low
2/3/2022Maxim GroupLower Target$88.00 ➝ $84.00High
2/3/2022OppenheimerLower Target$100.00 ➝ $90.00High
2/2/2022Morgan StanleyLower TargetEqual Weight$72.00 ➝ $69.00High
2/2/2022Truist FinancialLower TargetHold$77.00 ➝ $75.00High
2/2/2022Bank of AmericaLower TargetNeutral$73.00 ➝ $71.00Medium
2/2/2022BMO Capital MarketsLower TargetOutperform$85.00 ➝ $75.00Medium
2/2/2022Royal Bank of CanadaLower TargetOutperform$87.00 ➝ $85.00Medium
2/2/2022Wells Fargo & CompanyLower TargetEqual Weight$72.00 ➝ $70.00Medium
1/28/2022ArgusUpgradeHold ➝ Buy$75.00High
1/18/2022Morgan StanleyLower TargetEqual Weight$74.00 ➝ $72.00Low
1/14/2022BMO Capital MarketsInitiated CoverageBuy$85.00Low
1/6/2022Morgan StanleyDowngradeOverweight ➝ Equal Weight$84.00 ➝ $74.00Low
12/15/2021BMO Capital MarketsReiterated RatingBuyMedium
12/14/2021SVB LeerinkReiterated RatingBuyMedium
12/8/2021Wells Fargo & CompanyInitiated CoverageEqual Weight$72.00Medium
12/6/2021The Goldman Sachs GroupInitiated CoverageNeutral$80.00Low
11/19/2021Piper SandlerInitiated CoverageNeutral$77.00Medium
11/18/2021BMO Capital MarketsUpgradeMarket Perform ➝ Outperform$72.00 ➝ $85.00Medium
10/31/2021Evercore ISIReiterated RatingBuyMedium
10/29/2021SVB LeerinkLower TargetOutperform$77.00 ➝ $75.00High
10/12/2021Morgan StanleyBoost TargetOverweight$83.00 ➝ $84.00Medium
8/27/2021Morgan StanleyReiterated RatingBuy$83.00Low
8/23/2021Royal Bank of CanadaReiterated RatingBuyC$84.00Low
7/30/2021SVB LeerinkBoost TargetOutperform$74.00 ➝ $77.00Low
7/30/2021BMO Capital MarketsBoost TargetMarket Perform$67.00 ➝ $72.00Low
7/30/2021Royal Bank of CanadaBoost TargetOutperform$81.00 ➝ $84.00Medium
6/28/2021OppenheimerInitiated CoverageBuy$100.00Low
5/7/2021Jefferies Financial GroupReiterated RatingBuy$80.00Low
5/3/2021Morgan StanleyBoost TargetOverweight$81.00 ➝ $83.00High
4/30/2021SVB LeerinkBoost TargetOutperform$72.00 ➝ $74.00Medium
4/30/2021Needham & Company LLCReiterated RatingHoldHigh
4/19/2021Morgan StanleyLower TargetOverweight$87.00 ➝ $81.00Low
4/1/2021Sanford C. BernsteinUpgradeMarket Perform ➝ Outperform$80.00Medium
3/30/2021Redburn PartnersUpgradeNeutral ➝ BuyLow
2/11/2021SVB LeerinkLower TargetOutperform$73.00 ➝ $72.00Low
2/5/2021SVB LeerinkLower TargetOutperform$74.00 ➝ $73.00High
2/5/2021Credit Suisse GroupBoost TargetNeutral$65.00 ➝ $66.00High
2/5/2021Morgan StanleyBoost TargetOverweight$83.00 ➝ $87.00High
1/19/2021Morgan StanleyUpgradeEqual Weight ➝ Overweight$83.00High
1/4/2021GuggenheimUpgradeNeutral ➝ BuyN/A
12/22/2020Smith Barney CitigroupLower Target$75.00 ➝ $72.00Low
12/18/2020Truist FinancialLower Target$67.00 ➝ $625.00High
12/17/2020OppenheimerLower TargetOutperform$105.00 ➝ $100.00Low
12/16/2020BMO Capital MarketsLower TargetMarket Perform$64.00 ➝ $62.00Low
12/16/2020Credit Suisse GroupLower TargetNeutral$70.00 ➝ $65.00Low
12/16/2020Robert W. BairdBoost TargetNeutral$63.00 ➝ $67.00Low
12/15/2020Piper SandlerLower TargetOverweight$84.00 ➝ $80.00Low
12/14/2020Redburn PartnersInitiated CoverageNeutralLow
12/8/2020JPMorgan Chase & Co.Reiterated RatingHoldLow
11/3/2020Morgan StanleyReiterated RatingEqual Weight$67.00Low
10/29/2020Cantor FitzgeraldReiterated RatingOverweight$84.00 ➝ $86.00Medium
10/29/2020BMO Capital MarketsLower TargetMarket Perform$74.00 ➝ $64.00Medium
10/29/2020BarclaysLower Target$67.00 ➝ $62.00Medium
10/29/2020Wells Fargo & CompanyLower TargetEqual Weight$69.00 ➝ $63.00Low
10/29/2020Piper SandlerLower TargetOverweight$95.00 ➝ $84.00Medium
10/29/2020SVB LeerinkLower TargetOutperform$88.00 ➝ $79.00Low
10/28/2020UBS GroupInitiated CoverageNeutral$61.00Medium
9/30/2020Jefferies Financial GroupInitiated CoverageBuy$78.00Low
9/18/2020Royal Bank of CanadaBoost Target$82.00 ➝ $86.00Low
9/15/2020Royal Bank of CanadaLower TargetOutperform$84.00 ➝ $82.00Low
9/15/2020Maxim GroupUpgradeHold ➝ Buy$88.00Low
9/14/2020SVB LeerinkLower TargetOutperform$94.00 ➝ $88.00High
9/14/2020Raymond JamesReiterated RatingHoldHigh
9/10/2020OppenheimerBoost TargetOutperform$90.00 ➝ $105.00Medium
8/20/2020Truist FinancialLower Target$74.00 ➝ $67.00Low
8/19/2020Piper SandlerLower TargetOverweight$85.00 ➝ $83.00Medium
8/19/2020Jefferies Financial GroupLower Target$97.00 ➝ $78.00Medium
8/19/2020Wells Fargo & CompanyBoost TargetEqual Weight$69.00 ➝ $76.00High
8/19/2020BMO Capital MarketsBoost TargetMarket Perform$74.00 ➝ $79.00Medium
8/19/2020Cantor FitzgeraldLower TargetOverweight$86.00 ➝ $84.00Medium
8/7/2020JPMorgan Chase & Co.Reiterated RatingHoldLow
8/3/2020CitigroupBoost Target$78.00 ➝ $80.00Low
7/31/2020SVB LeerinkReiterated RatingBuy$95.00High
7/31/2020Cantor FitzgeraldReiterated RatingBuy$86.00High
7/31/2020Piper SandlerLower TargetOverweight$90.00 ➝ $85.00Medium
7/31/2020Credit Suisse GroupLower TargetNeutral$75.00 ➝ $73.00Medium
7/31/2020SunTrust BanksBoost TargetHold$73.00 ➝ $74.00Medium
7/31/2020Royal Bank of CanadaLower TargetOutperform$89.00 ➝ $87.00Medium
7/31/2020Morgan StanleyLower TargetEqual Weight$80.00 ➝ $79.00Medium
7/31/2020Wells Fargo & CompanyLower TargetEqual Weight$87.00 ➝ $76.00Medium
7/28/2020JPMorgan Chase & Co.Reiterated RatingHold$85.00Low
7/21/2020Jefferies Financial GroupReiterated RatingBuy$97.00Low
7/20/2020Credit Suisse GroupUpgradeUnderperform ➝ Neutral$64.00 ➝ $75.00Low
7/15/2020Morgan StanleyBoost TargetEqual Weight$77.00 ➝ $80.00Low
7/6/2020Royal Bank of CanadaReiterated RatingBuyLow
6/30/2020Needham & Company LLCReiterated RatingHoldHigh
6/29/2020Robert W. BairdReiterated RatingHold$76.00High
6/22/2020Jefferies Financial GroupReiterated RatingBuy$97.00Low
6/15/2020DZ BankReiterated RatingBuyMedium
6/8/2020Piper SandlerReiterated RatingBuy$90.00Low
6/3/2020Royal Bank of CanadaReiterated RatingBuy$88.00High
6/3/2020SVB LeerinkUpgradeMarket Perform ➝ Outperform$85.00 ➝ $94.00Low
6/2/2020Maxim GroupReiterated RatingHoldHigh
6/1/2020Needham & Company LLCReiterated RatingHoldHigh
5/26/2020SunTrust BanksUpgradeSell ➝ Hold$70.00 ➝ $73.00Medium
5/21/2020Piper SandlerReiterated RatingBuy$90.00Low
5/21/2020Robert W. BairdReiterated RatingHold$75.00Low
5/18/2020OppenheimerReiterated RatingBuyHigh
5/13/2020MizuhoReiterated RatingBuy$81.00Low
5/13/2020JPMorgan Chase & Co.Reiterated RatingHold$85.00High
5/5/2020Royal Bank of CanadaReiterated RatingBuy$88.00Low
5/1/2020Wells Fargo & CompanyReiterated RatingHold$84.00Low
5/1/2020SVB LeerinkBoost TargetMarket Perform$68.00 ➝ $85.00Low
5/1/2020OppenheimerBoost TargetOutperform$80.00 ➝ $90.00Low
5/1/2020Morgan StanleyBoost TargetEqual Weight$75.00 ➝ $77.00Low
5/1/2020Raymond JamesDowngradeOutperform ➝ Market PerformLow
5/1/2020SunTrust BanksDowngradeHold ➝ Sell$70.00Low
5/1/2020JPMorgan Chase & Co.DowngradeOverweight ➝ NeutralLow
4/30/2020Maxim GroupReiterated RatingHoldHigh
4/29/2020OppenheimerInitiated CoverageBuy$80.00Medium
4/29/2020Robert W. BairdReiterated RatingHold$76.00Medium
4/29/2020CfraBoost TargetSell$71.00 ➝ $74.00Medium
4/29/2020MizuhoReiterated RatingBuy$81.00Low
4/27/2020UBS GroupDowngradeBuy ➝ Neutral$77.00 ➝ $80.00Low
4/23/2020Royal Bank of CanadaReiterated RatingBuy$85.00Low
4/23/2020MizuhoInitiated CoverageBuy$81.00Low
4/23/2020Raymond JamesReiterated RatingBuy$80.00Low
4/20/2020BMO Capital MarketsDowngradeOutperform ➝ Market Perform$79.00Medium
4/20/2020Wells Fargo & CompanyDowngradeOverweight ➝ Equal Weight$87.00Medium
4/19/2020Needham & Company LLCReiterated RatingHoldHigh
4/18/2020Maxim GroupInitiated CoverageHoldHigh
4/17/2020Credit Suisse GroupReiterated RatingSell$60.00High
4/17/2020Royal Bank of CanadaReiterated RatingBuy$85.00High
4/17/2020JPMorgan Chase & Co.Reiterated RatingBuyHigh
4/17/2020CfraDowngradeHold ➝ SellHigh
4/16/2020Piper SandlerReiterated RatingBuy$90.00High
4/13/2020Jefferies Financial GroupReiterated RatingBuy$89.00High
4/13/2020CowenReiterated RatingBuy$80.00High
4/13/2020BMO Capital MarketsReiterated RatingOutperform ➝ Buy$79.00High
4/13/2020Needham & Company LLCReiterated RatingHoldLow
4/7/2020Cantor FitzgeraldBoost TargetOverweight$78.00 ➝ $86.00High
4/6/2020Credit Suisse GroupReiterated RatingSell$60.00High
3/31/2020Wolfe ResearchInitiated CoverageMarket Perform$65.00Low
3/30/2020SVB LeerinkReiterated RatingHold$68.00Low
3/25/2020Royal Bank of CanadaReiterated RatingBuy$83.00High
3/25/2020SunTrust BanksReiterated RatingHoldHigh
3/20/2020Piper SandlerUpgradeNeutral ➝ Overweight$70.00 ➝ $90.00High
3/18/2020Royal Bank of CanadaReiterated RatingBuy$83.00High
3/18/2020DZ BankUpgradeHold ➝ Buy$80.00High
3/9/2020Royal Bank of CanadaDowngradeTop Pick ➝ Outperform$86.00High
3/4/2020Wells Fargo & CompanyBoost TargetOverweight$81.00 ➝ $87.00Low
3/3/2020Credit Suisse GroupReiterated RatingUnderperformLow
3/2/2020MizuhoInitiated CoverageBuy$81.00Low
3/2/2020HC WainwrightDowngradeBuy ➝ NeutralHigh
2/28/2020DZ BankDowngradeBuy ➝ Hold$80.00High
2/27/2020BarclaysInitiated CoverageUnderweight$62.00High
2/24/2020SunTrust BanksReiterated RatingHold$70.00High
2/19/2020Royal Bank of CanadaReiterated RatingBuy$86.00Low
2/9/2020Maxim GroupReiterated RatingHoldLow
2/6/2020Sanford C. BernsteinDowngradeOutperform ➝ Market Perform$78.00 ➝ $70.00High
2/5/2020Piper SandlerLower Target$75.00 ➝ $70.00High
2/5/2020Bank of AmericaBoost TargetNeutral$70.00 ➝ $72.00Low
2/5/2020Credit Suisse GroupBoost TargetUnderperform$59.00 ➝ $60.00Low
2/5/2020JPMorgan Chase & Co.Reiterated RatingBuyMedium
2/5/2020Raymond JamesDowngradeStrong-Buy ➝ Outperform$81.00 ➝ $80.00Medium
1/21/2020GuggenheimDowngradeBuy ➝ NeutralLow
1/3/2020OppenheimerUpgradeMarket Perform ➝ OutperformLow
1/2/2020CowenReiterated RatingBuy$85.00Low
12/13/2019Credit Suisse GroupDowngradeNeutral ➝ Underperform$67.00 ➝ $63.00High
11/12/2019SunTrust BanksInitiated CoverageHold$70.00Low
10/25/2019GuggenheimSet TargetBuy$86.00High
10/25/2019Wells Fargo & CompanySet TargetBuy$81.00N/A
10/25/2019Robert W. BairdSet TargetHold$76.00N/A
10/25/2019Morgan StanleySet TargetHold$75.00N/A
10/25/2019OppenheimerLower TargetOutperform$85.00 ➝ $80.00Low
10/25/2019Maxim GroupDowngradeBuy ➝ HoldHigh
10/25/2019Cantor FitzgeraldLower TargetOverweight$88.00 ➝ $85.00High
10/16/2019Bank of AmericaInitiated CoverageNeutral$70.00Low
10/15/2019MizuhoSet TargetBuy$81.00Low
8/23/2019Raymond JamesSet TargetBuy$85.00Low
7/31/2019BMO Capital MarketsSet TargetBuy$82.00Low
7/31/2019CitigroupSet TargetBuy$78.00Low
7/31/2019Maxim GroupSet TargetBuy$84.00N/A
7/31/2019Credit Suisse GroupLower TargetNeutral$70.00 ➝ $67.00Medium
7/31/2019JPMorgan Chase & Co.Reiterated RatingBuy$85.00High
7/31/2019Raymond JamesBoost TargetStrong-Buy$83.00 ➝ $86.00High
7/29/2019Royal Bank of CanadaUpgradeOutperform ➝ Top Pick$91.00Low
7/15/2019Needham & Company LLCReiterated RatingHoldLow
7/15/2019Jefferies Financial GroupSet TargetBuy$95.00Low
7/15/2019MizuhoSet TargetBuy$88.00Low
7/15/2019Morgan StanleySet TargetHold$82.00Low
7/15/2019Cantor FitzgeraldSet TargetBuy$88.00Low
7/15/2019BMO Capital MarketsSet TargetBuy$76.00Low
7/15/2019Maxim GroupSet TargetBuy$84.00Low
7/15/2019Wells Fargo & CompanyUpgradeMarket Perform ➝ Outperform$68.00 ➝ $88.00High
7/12/2019OppenheimerSet TargetBuy$85.00High
7/2/2019JPMorgan Chase & Co.Reiterated RatingBuyLow
6/19/2019MizuhoReiterated RatingBuy$88.00Low
5/28/2019The Goldman Sachs GroupDowngradeNeutral ➝ Sell$70.00 ➝ $60.00High
5/22/2019CitigroupUpgradeNeutral ➝ Buy$66.80Low
5/20/2019Credit Suisse GroupInitiated CoverageNeutral$70.00Low
5/17/2019MizuhoSet TargetBuy$88.00Low
5/17/2019Evercore ISIReiterated RatingBuyLow
5/10/2019MizuhoSet TargetBuy$88.00High
5/7/2019JPMorgan Chase & Co.Reiterated RatingBuy$87.00Low
5/6/2019Needham & Company LLCReiterated RatingHoldHigh
5/3/2019Raymond JamesSet TargetBuy$83.00Low
5/3/2019CowenReiterated RatingBuyHigh
4/28/2019JPMorgan Chase & Co.Reiterated RatingBuyLow
4/26/2019Sanford C. BernsteinInitiated CoverageOutperform ➝ Outperform$82.00Medium
4/25/2019Cantor FitzgeraldReiterated RatingBuy$87.00Low
4/23/2019Raymond JamesSet TargetBuy$86.00Low
4/22/2019OppenheimerSet TargetBuy$85.00Low
4/22/2019MizuhoSet TargetBuy$88.00Low
4/12/2019MizuhoSet TargetBuy$88.00Low
4/10/2019UBS GroupUpgradeNeutral ➝ Buy$75.00 ➝ $77.00Low
3/29/2019Maxim GroupReiterated RatingBuy$84.00Medium
3/22/2019MizuhoSet TargetBuy$88.00Low
3/19/2019OppenheimerSet TargetBuy$85.00Medium
3/14/2019BMO Capital MarketsInitiated CoverageOutperform$78.00Medium
3/7/2019Piper Jaffray CompaniesSet TargetHold$75.00Medium
3/7/2019JPMorgan Chase & Co.Reiterated RatingBuyLow
2/26/2019MizuhoReiterated RatingBuy$88.00Low
2/12/2019Raymond JamesLower TargetStrong-Buy ➝ Strong-Buy$90.00 ➝ $85.00Low
2/12/2019CitigroupDowngradeBuy ➝ Neutral$100.00 ➝ $75.00Medium
2/11/2019Wells Fargo & CompanyDowngradeOutperform ➝ Market Perform$95.00 ➝ $68.00Medium
2/5/2019Maxim GroupSet TargetBuy$84.00Medium
2/5/2019Raymond JamesSet TargetBuy$90.00Medium
2/5/2019Wells Fargo & CompanyLower TargetOutperform$95.00 ➝ $89.00Low
2/5/2019CitigroupReiterated RatingBuy$100.00Low
1/3/2019CIBCUpgradeMarket Perform ➝ Outperform$85.00Low
1/3/2019OppenheimerUpgradeMarket Perform ➝ Outperform$85.00High
12/20/2018Raymond JamesSet TargetBuy$94.00High
12/19/2018Morgan StanleyBoost TargetEqual Weight ➝ Equal Weight$85.00 ➝ $86.00Medium
12/19/2018Cantor FitzgeraldReiterated RatingOverweight$92.00Medium
12/17/2018GuggenheimInitiated CoverageBuy$86.00Low
11/14/2018OppenheimerReiterated RatingHoldMedium
11/14/2018Needham & Company LLCReiterated RatingHoldMedium
11/1/2018Raymond JamesReiterated RatingBuyLow
11/1/2018MizuhoSet TargetBuy$94.00Medium
10/31/2018Evercore ISIReiterated RatingBuyMedium
10/26/2018MizuhoSet TargetBuy$94.00High
10/26/2018Raymond JamesLower TargetStrong-Buy ➝ Strong-Buy$97.00 ➝ $94.00Low
10/26/2018BarclaysBoost TargetOverweight ➝ Overweight$90.00 ➝ $95.00Medium
10/26/2018Piper Jaffray CompaniesDowngradeOverweight ➝ Neutral$85.00 ➝ $75.00High
10/26/2018Cantor FitzgeraldBoost TargetOverweight ➝ Overweight$87.00 ➝ $88.00Medium
10/1/2018Cantor FitzgeraldInitiated CoverageOverweight ➝ Overweight$87.00Low
9/12/2018Piper Jaffray CompaniesSet TargetBuy$85.00Medium
8/10/2018MizuhoReiterated RatingBuy$94.00Low
7/31/2018MizuhoSet TargetBuy$94.00Low
7/26/2018Morgan StanleyBoost TargetEqual Weight ➝ Equal Weight$81.00 ➝ $85.00Medium
7/26/2018Wells Fargo & CompanyBoost TargetOutperform$89.00 ➝ $95.00High
7/26/2018Robert W. BairdDowngradeOutperform ➝ Neutral$79.00High
6/28/2018Raymond JamesInitiated CoverageStrong-Buy$93.00Medium
5/30/2018Piper Jaffray CompaniesInitiated CoverageOverweight ➝ Buy$85.00Medium
5/2/2018Needham & Company LLCReiterated RatingHoldHigh
5/2/2018Morgan StanleyLower TargetEqual Weight ➝ Equal Weight$85.00 ➝ $81.00Low
5/2/2018BarclaysLower TargetOverweight ➝ Buy$95.00 ➝ $90.00High
5/2/2018SVB LeerinkSet TargetMarket Perform$80.00 ➝ $72.00High
4/17/2018Credit Suisse GroupSet TargetHold$80.00Low
3/6/2018BarclaysReiterated RatingOverweight ➝ Overweight$90.00 ➝ $95.00Low
2/23/2018Royal Bank of CanadaReiterated RatingBuy$94.00Low
2/22/2018SVB LeerinkReiterated RatingMkt Perform ➝ Market Perform$83.00 ➝ $80.00Low
2/12/2018MizuhoReiterated RatingBuy ➝ Buy$83.00 ➝ $95.00Low
2/8/2018BMO Capital MarketsBoost TargetOutperform ➝ Market Perform$86.00 ➝ $88.00High
2/8/2018CitigroupReiterated RatingBuy ➝ Buy$103.00 ➝ $105.00High
2/7/2018Credit Suisse GroupSet TargetHold$80.00High
2/7/2018BMO Capital MarketsReiterated RatingHoldHigh
2/7/2018SVB LeerinkLower TargetMarket Perform ➝ Market Perform$86.00 ➝ $83.00Low
2/7/2018Morgan StanleyLower TargetEqual Weight ➝ Equal Weight$87.00 ➝ $84.00Medium
2/7/2018Bank of AmericaBoost TargetNeutral ➝ Neutral$82.00 ➝ $87.00Medium
2/6/2018Maxim GroupSet TargetBuy$94.00High
2/5/2018MizuhoSet TargetBuy$83.00 ➝ $95.00High
1/30/2018CitigroupUpgradeNeutral ➝ Buy$88.80 ➝ $76.00Low
1/26/2018Jefferies Financial GroupUpgradeHold ➝ Buy$81.19 ➝ $93.00High
1/16/2018Wells Fargo & CompanyUpgradeMarket Perform ➝ Outperform$79.02 ➝ $96.00Low
1/3/2018Credit Suisse GroupSet TargetHold$80.00Low
1/3/2018BMO Capital MarketsReiterated RatingHoldLow
12/21/2017OppenheimerReiterated RatingHoldMedium
12/20/2017Credit Suisse GroupDowngradeOutperform ➝ Neutral$74.35 ➝ $80.00Low
12/11/2017Maxim GroupSet TargetBuy$94.00Medium
12/7/2017Credit Suisse GroupReiterated RatingBuy$82.00Medium
11/30/2017Maxim GroupUpgradeHold ➝ Buy$73.67 ➝ $94.00Low
11/13/2017ArgusDowngradeBuy ➝ Hold$73.25 ➝ $73.77N/A
11/8/2017MizuhoBoost TargetBuy$77.00 ➝ $83.00N/A
10/29/2017MizuhoSet TargetBuy$77.00N/A
10/27/2017Maxim GroupReiterated RatingHoldN/A
10/27/2017BMO Capital MarketsLower TargetOutperform$89.00 ➝ $83.00N/A
10/25/2017JPMorgan Chase & Co.Set TargetBuy$85.00N/A
10/20/2017BMO Capital MarketsReiterated RatingHold$82.00N/A
10/19/2017Maxim GroupReiterated RatingHoldN/A
10/19/2017SVB LeerinkBoost TargetMarket Perform$84.00 ➝ $85.00N/A
10/19/2017William BlairReiterated RatingBuyN/A
10/19/2017Berenberg BankSet TargetBuy$96.00N/A
10/11/2017BarclaysReiterated RatingOverweight ➝ Overweight$90.00N/A
10/6/2017Morgan StanleyReiterated RatingEqual Weight$77.00 ➝ $83.00N/A
10/5/2017SVB LeerinkBoost TargetMarket Perform$87.00 ➝ $89.00N/A
10/5/2017CIBCInitiated CoverageMarket Perform ➝ Market PerformN/A
10/5/2017OppenheimerInitiated CoverageMarket PerformN/A
10/5/2017Jefferies Financial GroupInitiated CoverageHold ➝ PositiveN/A
10/4/2017Bank of AmericaLower TargetNeutral$87.00 ➝ $86.00Low
10/4/2017Jefferies Financial GroupReiterated RatingHold ➝ Hold$93.00Low
(Data available from 10/2/2017 forward)

News Sentiment Rating

0.10 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 10 very positive mentions
  • 51 positive mentions
  • 7 negative mentions
  • 5 very negative mentions
3/6/2022
  • 7 very positive mentions
  • 11 positive mentions
  • 6 negative mentions
  • 5 very negative mentions
4/5/2022
  • 12 very positive mentions
  • 36 positive mentions
  • 7 negative mentions
  • 6 very negative mentions
5/5/2022
  • 12 very positive mentions
  • 40 positive mentions
  • 4 negative mentions
  • 1 very negative mentions
6/4/2022
  • 16 very positive mentions
  • 29 positive mentions
  • 5 negative mentions
  • 5 very negative mentions
7/4/2022
  • 14 very positive mentions
  • 35 positive mentions
  • 4 negative mentions
  • 1 very negative mentions
8/3/2022
  • 14 very positive mentions
  • 46 positive mentions
  • 1 negative mentions
  • 4 very negative mentions
9/2/2022
  • 15 very positive mentions
  • 27 positive mentions
  • 12 negative mentions
  • 12 very negative mentions
10/2/2022

Current Sentiment

  • 15 very positive mentions
  • 27 positive mentions
  • 12 negative mentions
  • 12 very negative mentions

Recent Stories by Sentiment

Gilead Sciences logo
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of coronavirus disease 2019; and Epclusa, Harvoni, Vosevi, Vemlidy, and Viread for the treatment of liver diseases. It also offers Yescarta, Tecartus, Trodelvy, and Zydelig products for the treatment of hematology, oncology, and cell therapy patients. In addition, the company provides Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; Ranexa, an oral formulation for the treatment of chronic angina; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections. Gilead Sciences, Inc. has collaboration agreements with Arcus Biosciences, Inc.; Pionyr Immunotherapeutics Inc.; Tizona Therapeutics, Inc.; Tango Therapeutics, Inc.; Jounce Therapeutics, Inc.; Galapagos NV; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Gadeta B.V.; Bristol-Myers Squibb Company; Dragonfly Therapeutics, Inc.; and Merck & Co, Inc. The company was incorporated in 1987 and is headquartered in Foster City, California.
Read More

Today's Range

Now: $61.69
Low: $61.61
High: $63.58

50 Day Range

MA: $63.37
Low: $59.54
High: $68.01

52 Week Range

Now: $61.69
Low: $57.17
High: $74.12

Volume

8,794,843 shs

Average Volume

8,097,092 shs

Market Capitalization

$77.32 billion

P/E Ratio

18.81

Dividend Yield

4.63%

Beta

0.31

Frequently Asked Questions

What sell-side analysts currently cover shares of Gilead Sciences?

The following equities research analysts have issued stock ratings on Gilead Sciences in the last year: Argus, Bank of America Co., Barclays PLC, BMO Capital Markets, Cantor Fitzgerald, Evercore ISI, Maxim Group, Mizuho, Morgan Stanley, Oppenheimer Holdings Inc., Piper Sandler, Royal Bank of Canada, StockNews.com, SVB Leerink LLC, The Goldman Sachs Group, Inc., TheStreet, Truist Financial Co., and Wells Fargo & Company.
View the latest analyst ratings for GILD.

What is the current price target for Gilead Sciences?

15 Wall Street analysts have set twelve-month price targets for Gilead Sciences in the last year. Their average twelve-month price target is $73.53, suggesting a possible upside of 19.2%. Oppenheimer Holdings Inc. has the highest price target set, predicting GILD will reach $90.00 in the next twelve months. Barclays PLC has the lowest price target set, forecasting a price of $56.00 for Gilead Sciences in the next year.
View the latest price targets for GILD.

What is the current consensus analyst rating for Gilead Sciences?

Gilead Sciences currently has 1 sell rating, 9 hold ratings and 4 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in GILD, but not buy more shares or sell existing shares.
View the latest ratings for GILD.

What other companies compete with Gilead Sciences?

Other companies that are similar to Gilead Sciences include Biogen, Amgen, Seagen, Moderna and BioNTech. Learn More about companies similar to Gilead Sciences.

How do I contact Gilead Sciences' investor relations team?

Gilead Sciences' physical mailing address is 333 LAKESIDE DRIVE, FOSTER CITY CA, 94404. The biopharmaceutical company's listed phone number is (650) 574-3000 and its investor relations email address is [email protected] The official website for Gilead Sciences is www.gilead.com. Learn More about contacing Gilead Sciences investor relations.